Release Date: 16/05/23 08:17 Summary: Change of substantial holding from RMS Price Sensitive: No Download Document 97.08KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%